<scp>EGFR</scp> inhibition in <scp>EGFR</scp> ‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment-Reference-Cited by-同舟云学术

EGFR inhibition in EGFR ‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment

Published:2022-12-26 Issue:4 Volume:114 Page:1270-1283
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Shiiya Akihiko¹,Noguchi Takuro¹²^ORCID,Tomaru Utano³,Ariga Shin¹^ORCID,Takashima Yuta⁴,Ohhara Yoshihito¹,Taguchi Jun¹,Takeuchi Satoshi¹,Shimizu Yasushi¹,Kinoshita Ichiro¹⁵,Koizumi Tomonobu²,Matsuno Yoshihiro³,Shinagawa Naofumi⁴,Sakakibara‐Konishi Jun⁴^ORCID,Dosaka‐Akita Hirotoshi¹

Affiliation:

1. Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

2. Department of Hematology and Medical Oncology Shinshu University School of Medicine Matsumoto Japan

3. Department of Surgical Pathology Hokkaido University Hospital Sapporo Japan

4. Department of Respiratory Medicine, Faculty of Medicine Hokkaido University Sapporo Japan

5. Division of Clinical Cancer Genomics Hokkaido University Hospital Sapporo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15701

Reference42 articles.

1. EGFR Antagonists in Cancer Treatment

2. Epidermal growth factor receptor mutations in lung cancer

3. Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

4. Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer

5. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies;Immunology;2024-08-11

2. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions;Cancer Immunology, Immunotherapy;2024-01-27

3. LINC00968 and LINC00511 Regulate Gefitinib-Induced Proliferation Inhibition and Apoptosis and Drug Resistance-Related Genes in Non-Small-Cell Lung Cancer;J BIOL REG HOMEOS AG;2023

4. Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy;Frontiers in Immunology;2023-11-13

5. Osimertinib resistance prognostic gene signature: STRIP2 is associated with immune infiltration and tumor progression in lung adenocarcinoma;Journal of Cancer Research and Clinical Oncology;2023-08-31